New Key Statistics Module, Z-Score and F-Score
GREY:GLKQY Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | 2,619.17 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.84 |
| Price/Sales | 3.87 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -3.24 |
| 10-y EBITDA Growth Rate % | 1.90 |
| 5-y EBITDA Growth Rate % | -10.50 |
| y-y EBITDA Growth Rate % | 22.20 |
| EV-to-EBIT | 57.40 |
| EV-to-EBITDA | 33.67 |
| PEG | -- |
| Shares Outstanding M | 282.17 |
| Net Margin (%) | -11.06 |
| Operating Margin % | 6.80 |
| Pre-tax Margin (%) | 2.93 |
| Quick Ratio | 0.84 |
| Current Ratio | 1.28 |
| ROA % (ttm) | -7.32 |
| ROE % (ttm) | -14.76 |
| ROIC % (ttm) | -25.27 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.14 |
GLKQY Number of Guru Trades
GLKQY Volume of Guru Trades
Gurus Latest Trades with GREY:GLKQY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:GLKQY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Glenmark Pharmaceuticals Ltd Insider Transactions
No Available Data
News about GREY:GLKQY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers